Target finder


Insert sequence accession number

Cancel

Record ID: NRN_AX268220

Description:Sequence 14 from Patent WO0175135. Sequence 7 from patent US 6969598. Retinoic acid receptor beta-2, its antagonists, and gene therapy vectors for the treatment of neurological disorders.
Length:5993 bp
Found in databases: nrnl1
Found in the following 4 patents: WO0175135 (lens, espacenet) US6969598 (lens, espacenet) US2003113898 (lens, espacenet) JP2003533184 (lens, espacenet)

2 amplicons

View all records targeted by these methods

View these methods in JRC GMO-Matrix



0 599 1199 1798 2397 2997 3596 4195 4794 5394 5993 QL-ELE-00-002 QL-ELE-00-003

Legend

Event-specific method
Element-specific method
Construct-specific method
Taxon-specific method

Record ID Database Record description Record length Taxon Method Amplicon size Match details
NRN_AX268220 nrnl1 Sequence 14 from Patent WO0175135. ... 5993 bp unidentified QL-ELE-00-002 215 bp View
NRN_AX268220 nrnl1 Sequence 14 from Patent WO0175135. ... 5993 bp unidentified QL-ELE-00-003 173 bp View


Related publications:

Petrillo, M., et al. “JRC GMO-Amplicons: A Collection of Nucleic Acid Sequences Related to Genetically Modified Organisms.” Database (Oxford), vol. 2015 bav101, 30 Sep. 2015, doi:10.1093/database/bav101. 

Angers-Loustau, A., et al. “Using the EURL GMFF Online Bioinformatics Resources: A how-to Guide for Practical JRC GMO-Matrix and JRC GMO-Amplicons Case Uses.” European Commission, Ispra, JRC101853, 2016.